KRAS and colorectal carcinoma: On the other hand, activation of the KRAS pathway can trigger and upregulate some oncomiRs, such as miR-210 and miR-181a with a role in CRC development and progression [73] or miR200c that has a pivotal role in CRC aggressiveness and metastasis [74].